Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Taletrectinib bulk supplier for pharma manufacturers

Taletrectinib 200 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 200 mg

Reference Brands: Ibtrozi (USA)

Category: Oncology Cancer Care

Taletrectinib is a next-generation tyrosine kinase inhibitor that targets ROS1 and NTRK fusion proteins. It is used to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It works by blocking the abnormal ROS1 signaling that drives cancer cell growth and proliferation. Because it is taken once daily, on an empty stomach (2 hours before or after food), it has specific administration requirements.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Taletrectinib — third party manufacturing & bulk supply

Taletrectinib 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Taletrectinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Taletrectinib →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Taletrectinib is used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that has a ROS1 gene fusion. It helps slow or stop the growth of cancer cells by blocking ROS1 and certain NTRK pathways.

Taletrectinib is a small-molecule kinase inhibitor formulated as taletrectinib adipate. It works by inhibiting ROS1 and NTRK receptors that drive the growth of certain cancer cells.

The trade name is Ibtrozi.

It is developed and marketed by Nuvation Bio along with partnered manufacturers for distribution.

The generic name is taletrectinib, commonly available as taletrectinib adipate.

The brand name is Ibtrozi.

It is manufactured in authorized facilities in the United States and partner regions for global supply.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.